Original articleSkin mapping for the classification of generalized morphea
Section snippets
Methods
This is a 2-part cross-sectional study of participants of the prospective MAC cohort at the time of their enrollment. First, computerized lesion mapping was used to characterize lesion distribution patterns (discovery cohort) in generalized morphea, which created 2 proposed subsets of generalized morphea. Secondly, these distribution patterns were applied to an independent set of participants at their enrollment into the MAC cohort (validation cohort).
To create the discovery cohort, a
Participants
In all, 73 participants met inclusion criteria for the discovery cohort (of 93 patients with generalized morphea enrolled in the MAC cohort at that time). We also identified 20 separate patients with multiple linear lesions meeting criteria for generalized morphea as defined by Laxer and Zulian5 (of 217 total patients with linear morphea). The clinical and demographic features of these patients were compared with the 73 participants with generalized, but not linear, lesions. The multiple linear
Discussion
The demographic and clinical features of generalized morphea are poorly defined, to the detriment of studies aimed at identifying genetic and mechanistic features. We performed a cross-sectional study using computerized lesion mapping to more accurately identify disease subsets based on distribution of cutaneous lesions, and identified 2 clinically relevant subsets of generalized morphea with distinct demographic and clinical features.
Initial analysis revealed that current criteria for
References (20)
- et al.
Classification of morphea (localized scleroderma)
Mayo Clinic Proc
(1995) - et al.
The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the Morphea in Adults and Children cohort IV
J Am Acad Dermatol
(2014) - et al.
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease
Blood
(2007) - et al.
Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center
J Am Acad Dermatol
(2012) Gender differences in systemic lupus erythematosus
Gend Med
(2004)- et al.
Localized scleroderma is an autoimmune disorder
Rheumatology
(2005) - et al.
The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993
J Rheumatol
(1997) - et al.
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis
Arthritis Rheum
(2007) - et al.
Localized scleroderma
Curr Opin Rheumatol
(2006) - et al.
Morphea in adults and children cohort III: nested case-control study–the clinical significance of autoantibodies in morphea
JAMA Dermatol
(2013)
Cited by (10)
Morphea patients with mucocutaneous involvement: A cross-sectional study from the Morphea in Adults and Children (MAC) cohort
2021, Journal of the American Academy of DermatologyCitation Excerpt :Although similarities exist between morphea and LSA, their relationship is debated in the literature. In our study, 59.2% of patients with genital involvement also had extragenital lesions of LSA typically overlying plaques of morphea.20 These patients had the consequent well-documented influence on function and life quality associated with genital LSA,21 as evidenced by their median Dermatology Life Quality Index scores (6; IQR 4-9), which were higher compared with those of patients with oral involvement (3; IQR 0-5.5) and no mucocutaneous involvement (4; IQR 1-9).
Isomorphic and symmetric adult-onset generalized morphea are associated with distinctive clinical features: A retrospective multicenter study
2021, Journal of the American Academy of DermatologyRF - Generalized Morphea: Definition and Associations
2021, Actas Dermo-SifiliograficasConnective Tissue Disease: Current Concepts
2019, Dermatologic ClinicsCitation Excerpt :This variability can impede clinical care and research, akin to CLE described earlier. Recently, Teske and colleagues54 used computerized lesion mapping to objectively determine the cutaneous distribution of lesions in patients with generalized morphea. Their analysis suggests there are 3 groups of generalized morphea patients with distinct clinical and demographic features.
Research for this manuscript was supported in part by National Institutes of Health (NIH) grant no. K23AR056303-5. This work was conducted with support from the University of Texas-Science and Technology Acquisition and Retention Program (UT-STAR), NIH/National Center for Research Resources (NCRR) grant number 4UL1TR001105-04/National Center for Advancing Translational Sciences grant no. UL1TR000451. The content is solely the responsibility of the authors and does not necessarily represent the official views of UT-STAR, University of Texas Southwestern Medical Center at Dallas and its affiliated academic and health care centers, NCRR, or NIH.
Conflicts of interest: None declared.
Reprints not available from the authors.